Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.25 Million EUR | -1.28% |
| 2022 | -14.07 Million EUR | -466.48% |
| 2021 | -2.48 Million EUR | 74.17% |
| 2020 | -9.62 Million EUR | 6.18% |
| 2019 | -10.25 Million EUR | -551.17% |
| 2018 | -1.57 Million EUR | -8.17% |
| 2017 | -1.45 Million EUR | -231.88% |
| 2016 | 1.1 Million EUR | -53.18% |
| 2015 | 2.35 Million EUR | -91.22% |
| 2014 | 26.84 Million EUR | 310.95% |
| 2013 | -12.72 Million EUR | -47.98% |
| 2012 | -8.59 Million EUR | -355.46% |
| 2011 | -1.88 Million EUR | -195.4% |
| 2010 | 1.97 Million EUR | 123.36% |
| 2009 | 886 Thousand EUR | 132.31% |
| 2008 | -2.74 Million EUR | 35.89% |
| 2007 | -4.27 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.84 Million EUR | 0.0% |
| 2023 Q3 | -2.51 Million EUR | 26.18% |
| 2023 Q4 | -2.51 Million EUR | 0.0% |
| 2023 FY | -14.25 Million EUR | -1.28% |
| 2023 Q1 | -4.6 Million EUR | 51.72% |
| 2023 Q2 | -3.41 Million EUR | 25.95% |
| 2022 FY | -14.07 Million EUR | -466.48% |
| 2022 Q2 | -2.97 Million EUR | -31.41% |
| 2022 Q3 | -4.77 Million EUR | -60.33% |
| 2022 Q1 | -2.26 Million EUR | -131.17% |
| 2022 Q4 | -9.54 Million EUR | -100.0% |
| 2021 Q1 | -752.5 Thousand EUR | 86.8% |
| 2021 Q3 | -528 Thousand EUR | 66.48% |
| 2021 Q2 | -1.57 Million EUR | -109.3% |
| 2021 Q4 | -980 Thousand EUR | -85.61% |
| 2021 FY | -2.48 Million EUR | 74.17% |
| 2020 Q1 | -1.96 Million EUR | 68.61% |
| 2020 Q2 | -1.83 Million EUR | 6.52% |
| 2020 FY | -9.62 Million EUR | 6.18% |
| 2020 Q3 | -2.84 Million EUR | -55.37% |
| 2020 Q4 | -5.69 Million EUR | -100.0% |
| 2019 Q3 | -3.12 Million EUR | -132.69% |
| 2019 Q2 | -1.34 Million EUR | 32.95% |
| 2019 Q1 | -2 Million EUR | -540.96% |
| 2019 FY | -10.25 Million EUR | -551.17% |
| 2019 Q4 | -6.25 Million EUR | -100.0% |
| 2018 Q4 | -312.5 Thousand EUR | 0.0% |
| 2018 Q2 | -914 Thousand EUR | -92.42% |
| 2018 FY | -1.57 Million EUR | -8.17% |
| 2018 Q1 | -475 Thousand EUR | 26.98% |
| 2018 Q3 | -312.5 Thousand EUR | 65.81% |
| 2017 Q2 | -343 Thousand EUR | -342.58% |
| 2017 Q3 | -650.5 Thousand EUR | -89.65% |
| 2017 Q4 | -650.5 Thousand EUR | 0.0% |
| 2017 Q1 | -77.5 Thousand EUR | -108.38% |
| 2017 FY | -1.45 Million EUR | -231.88% |
| 2016 Q4 | 924.5 Thousand EUR | 0.0% |
| 2016 FY | 1.1 Million EUR | -53.18% |
| 2016 Q2 | -385 Thousand EUR | -3.36% |
| 2016 Q3 | 924.5 Thousand EUR | 340.13% |
| 2016 Q1 | -372.5 Thousand EUR | -110.72% |
| 2015 Q4 | 3.47 Million EUR | 789.48% |
| 2015 FY | 2.35 Million EUR | -91.22% |
| 2015 Q3 | -504 Thousand EUR | -37.7% |
| 2015 Q2 | -366 Thousand EUR | -48.18% |
| 2015 Q1 | -247 Thousand EUR | -100.86% |
| 2014 Q4 | 28.73 Million EUR | 7860.39% |
| 2014 Q3 | 361 Thousand EUR | 128.01% |
| 2014 Q2 | -1.28 Million EUR | -28.9% |
| 2014 Q1 | -1 Million EUR | 85.72% |
| 2014 FY | 26.84 Million EUR | 310.95% |
| 2013 Q4 | -7 Million EUR | -501.29% |
| 2013 Q3 | -1.16 Million EUR | 47.24% |
| 2013 Q2 | -2.2 Million EUR | 5.92% |
| 2013 Q1 | -2.34 Million EUR | 63.4% |
| 2013 FY | -12.72 Million EUR | -47.98% |
| 2012 Q1 | -1.33 Million EUR | -273.53% |
| 2012 Q2 | -1.11 Million EUR | 16.08% |
| 2012 Q3 | 263 Thousand EUR | 123.55% |
| 2012 FY | -8.59 Million EUR | -355.46% |
| 2012 Q4 | -6.41 Million EUR | -2538.4% |
| 2011 Q4 | 767 Thousand EUR | 238.2% |
| 2011 Q3 | -555 Thousand EUR | 50.18% |
| 2011 Q2 | -1.11 Million EUR | -12.98% |
| 2011 FY | -1.88 Million EUR | -195.4% |
| 2011 Q1 | -986 Thousand EUR | -156.9% |
| 2010 FY | 1.97 Million EUR | 123.36% |
| 2010 Q4 | 1.73 Million EUR | 222.72% |
| 2010 Q3 | 537 Thousand EUR | -14.35% |
| 2010 Q2 | 627 Thousand EUR | 168.38% |
| 2010 Q1 | -917 Thousand EUR | 0.0% |
| 2009 FY | 886 Thousand EUR | 132.31% |
| 2008 FY | -2.74 Million EUR | 35.89% |
| 2007 FY | -4.27 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 498.99 Million EUR | 102.857% |
| Fresenius SE & Co. KGaA | -594 Million EUR | 97.6% |
| LIMES Schlosskliniken AG | 3.39 Million EUR | 519.757% |
| M1 Kliniken AG | 10.27 Million EUR | 238.764% |
| MEDICLIN Aktiengesellschaft | -10.77 Million EUR | -32.302% |
| RHÖN-KLINIKUM Aktiengesellschaft | 38.71 Million EUR | 136.828% |
| VITA 34 AG | -1.86 Million EUR | -664.45% |